Pfizer Says Its Vaccine Is Highly Protective in Children 5 to 11


By BY SHARON LAFRANIERE AND NOAH WEILAND
U.S.
https://ift.tt/3pqqcHu
The findings could add momentum for F.D.A. authorization of the pediatric dose, perhaps next week, a long-awaited development that would affect 28 million children.
New York Times
Clinical Trials, Coronavirus (2019-nCoV), Vaccination and Immunization, Children and Childhood, Drugs (Pharmaceuticals)
October 22, 2021 at 11:39PM

Popular posts from this blog

Why Do We Think It's Okay to Invade Strangers' Privacy?

Why American Spies Worry When Trump Meets Putin